Independent Financial Information Made Easy
The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.
Devon -based Zynerba is set to be acquired by Harmony Biosciences Holdings in a $2 million deal. The company is a commercial-stage pharmaceutical company. HRMY: Lowering target price to $34.00 has an Investment Rating of HOLD; a target price of $34.000000; an Industry Subrating of Medium; a Management Subrating. Harmony Biosciences Holdings, Inc. (HRMY) Q2 2023 Earnings Call Transcript.
Open: 32.78 Close: 32.14 Change: -0.64
Read more →Open: 32.04 Close: 32.34 Change: 0.3
Read more →